We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novo Nordisk Issued Subpoena Over Marketing of Diabetes Drugs
Novo Nordisk Issued Subpoena Over Marketing of Diabetes Drugs
February 18, 2011
Novo Nordisk has been hit with a subpoena from the U.S. Attorney in Massachusetts seeking information on the company’s marketing and promotion practices for several of its products.